Investment
Features
FeesSafety
Academy
More
Pluang+

Compare T1 Energy Inc. Common Stock (TE) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

T1 Energy Inc. Common StockTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

T1 Energy Inc. Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? T1 Energy Inc. Common Stock trades at $2.81 (market cap $946.42M), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Vir Biotechnology Inc. Common Stock is the larger of the two by market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, T1 Energy Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold T1 Energy Inc. Common Stock for 0 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

TEVIR
Market Cap
$946.42M$1.80B
Volume
12,898,7741,782,836
Sector
IndustrialsHealth
52-Week High
$12.04$11.78
52-Week Low
$2.72$5.12
Typical Hold Time
0 Days0 Days
Enterprise Value
$1.72B$1.36B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

T1 Energy Inc. Common Stock

T1 Energy (TE) trades at $3.16, down 1.56% today, reflecting ongoing investor caution despite a mixed earnings history. The company shows significant revenue growth from $755M in 2025 to $997M in 2026 but remains deeply unprofitable with a -38.49% net margin. Recent news highlights strategic moves toward vertical integration in solar manufacturing and energy storage, including the G2_Austin facility development and new supply agreements, which are central to its growth narrative.

The investment case hinges on execution of vertical integration and policy tailwinds, offering substantial upside to the $8 consensus target, but high execution risk, persistent losses, and regulatory scrutiny present clear dangers. Analyst sentiment is mixed with a Moderate Buy rating, yet the stock's viability depends heavily on future profitability improvements from 2027 onward.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

TE
100% Buy0% Sell
Avg holding period · 0 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

About T1 Energy Inc. Common Stock

T1 Energy Inc. manufactures photovoltaic solar modules and cells in US, operating a solar manufacturing facility in Texas acquired from Trina Solar. The company was formerly known as FREYR Battery before rebranding as T1 Energy in 2025 and changing its NYSE ticker from FREY to TE.

Read more on TE →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →